• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.64% Nasdaq Down 0.55%

    Actavis plc (ACT)

    -NYSE
    306.81 Down 6.27(2.00%) 4:05PM EDT
    |After Hours : 306.79 Down 0.02 (0.00%) 4:40PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:313.08
    Open:313.20
    Bid:305.86 x 100
    Ask:307.78 x 100
    1y Target Est:348.37
    Beta:0.86
    Earnings Date:Aug 3 - Aug 7 (Est.)
    Day's Range:306.35 - 314.18
    52wk Range:201.91 - 317.72
    Volume:2,459,983
    Avg Vol (3m):2,986,200
    Market Cap:120.41B
    P/E (ttm):N/A
    EPS (ttm):-7.42
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ACTDown 2.00%120.41B
    MYLDown 0.07%35.59B
    NVSDown 1.46%248.64B
    TEVADown 1.22%50.96B

    Key Statistics

    Forward P/E (1 yr):14.30
    P/S (ttm):8.39
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :17.85
    Quarterly EPS Est (Jun-15) :4.40
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):1.04

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Actavis plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes generic, branded generic, branded, biosimilar, and over-the-counter (OTC) pharmaceutical products. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback